Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?

Subjects

Subjects :

Humans
Carbazoles pharmacology
Carbazoles therapeutic use
Receptor Protein-Tyrosine Kinases
Protein Kinase Inhibitors therapeutic use
Lung Neoplasms drug therapy
Carcinoma, Non-Small-Cell Lung drug therapy

Details

Language :

English

ISSN :

1556-1380

Volume :

18

Issue :

3

Database :

MEDLINE

Journal :

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Publication Type :

Editorial & Opinion

Accession number :

36842817

Full Text :

https://doi.org/10.1016/j.jtho.2022.11.028